BPG is committed to discovery and dissemination of knowledge
Featured Articles
3/22/2023 11:42:05 AM | Browse: 124 | Download: 357
Publication Name World Journal of Hepatology
Manuscript ID 81123
Country Malaysia
Received
2022-10-27 06:03
Peer-Review Started
2022-10-27 06:07
To Make the First Decision
Return for Revision
2022-12-31 06:40
Revised
2023-01-17 07:01
Second Decision
2023-03-03 03:22
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2023-03-03 09:01
Articles in Press
2023-03-03 09:01
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2023-03-07 00:51
Publish the Manuscript Online
2023-03-22 11:20
ISSN 1948-5182 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Nanoscience & Nanotechnology
Manuscript Type Basic Study
Article Title mRNA transcriptome profiling of human hepatocellular carcinoma cells HepG2 treated with Catharanthus roseus-silver nanoparticles
Manuscript Source Invited Manuscript
All Author List Nur Asna Azhar, Siti Aishah Abu Bakar, Marimuthu Citartan and Nor Hazwani Ahmad
Funding Agency and Grant Number
Funding Agency Grant Number
Ministry of Higher Education Malaysia FRGS/1/2015/SG03/USM/03/1
Corresponding Author Nor Hazwani Ahmad, PhD, Senior Lecturer, Department of Biomedical Science, Advanced Medical and Dental Institute, Universiti Sains Malaysia, Jalan Tun Hamdan Sheikh Tahir, Kepala Batas 13200, Pulau Pinang, Malaysia. norhazwani@usm.my
Key Words Catharanthus roseus; HepG2; Silver nanoparticles; Transcriptome; oxidative stress; Apoptosis; Cell cycle
Core Tip Despite the increased attention on cancer nanomedicine which is advantageous to overcome the limitations of conventional cancer treatment, the information on the selectivity and detailed mechanisms at the cellular and molecular level remain unclear. To evaluate its selectivity effects, the proliferative activity of both liver cancer cells HepG2 and normal liver cells THLE-3 in response to Catharanthus roseus-silver nanoparticles (C. roseus-AgNPs) was assessed. To determine the possible signalling pathways induced by the C. roseus-AgNPs, the mRNA transcriptome profiling of hepatocellular carcinoma cell line HepG2 was performed, highlighting the expression of genes associated with oxidative stress, apoptosis, and cell cycle arrest. The elucidation of its selectivity effects and detailed wide genome screening would enlighten the cellular and molecular signalling pathways and provide a strong basis towards the development of C. roseus-AgNPs as an anticancer drug for liver cancer.
Publish Date 2023-03-22 11:20
Citation Azhar NA, Abu Bakar SA, Citartan M, Ahmad NH. mRNA transcriptome profiling of human hepatocellular carcinoma cells HepG2 treated with Catharanthus roseus-silver nanoparticles. World J Hepatol 2023; 15(3): 393-409
URL https://www.wjgnet.com/1948-5182/full/v15/i3/393.htm
DOI https://dx.doi.org/10.4254/wjh.v15.i3.393
Full Article (PDF) WJH-15-393-with-cover.pdf
Full Article (Word) WJH-15-393.docx
Manuscript File 81123_Auto_Edited-JLW.docx
Answering Reviewers 81123-Answering reviewers.pdf
Audio Core Tip 81123-Audio core tip.mp3
Biostatistics Review Certificate 81123-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form 81123-Conflict-of-interest statement.pdf
Copyright License Agreement 81123-Copyright license agreement.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s) 81123-Grant application form(s).pdf
Non-Native Speakers of English Editing Certificate 81123-Language certificate.pdf
Supplementary Material 81123-Supplementary material.pdf
Peer-review Report 81123-Peer-review(s).pdf
Scientific Misconduct Check 81123-Bing-Chang KL-2.png
Scientific Editor Work List 81123-Scientific editor work list.pdf